mRNA-1608 Herpes Vaccine - Precision Vaccinations News
WEBFeb 18, 2022 · mRNA-1608 Herpes Vaccine Candidate Clinical Trials, Dosage, Indication, News, Side Effects. Moderna Inc.'s herpes simplex virus vaccine candidate is a Messenger RNA () vaccine targeted against HSV-2 disease.On February 18, 2022, Moderna Inc. stated that it expects an HSV-2 vaccine could provide cross-protection against HSV-1. With mRNA-1608, Moderna aims to induce a strong antibody response ...
Herpes Vaccine Candidates — Precision Vaccinations News
WEBSep 12, 2024 · Women comprise up to 65% of infections in the United States and worldwide. As of September 12, 2024, herpes vaccine candidates conducting clinical trials include: mRNA-1608 is an mRNA vaccine candidate against HSV-2 disease. The mRNA-1608-P101 phase 1 study launched on September 6, 2023, and is forecasted to be completed on June 4, 2025.
HSV Treatment Readies for Approval — Precision Vaccinations News
WEBMar 29, 2023 · A recently published Original Article reported positive news regarding the First-in-Human clinical trials assessing Pritelivir, a Nonnucleoside Helicase-Primase Inhibitor targeting the Herpes Simplex Virus (HSV). As an active ingredient in a new chemical class (thiazolylamides), Pritelivir is active against both types of …
What’s the Difference Between Shingles and Chickenpox Vaccines?
WEBNov 2, 2017 · Conversely, the Zostavax, the traditional chickenpox vaccine, offers protection against shingles by only 51 percent, and the risk of PHN by 67 percent, according to the CDC. In addition, Zostavax’s effectiveness appears to last just five years, according to the CDC. Like every vaccine, Shingrix has the potential for side effects.
Uromune MV140 Urinary Tract Infection (UTI) Vaccine
WEBUromune MV140 Recurrent Urinary Tract Infection (rUTI) Vaccine Clinical Trials, Dosage, Indication, Side Effects. Immunotek S.L. Uromune™ MV140 is an inactivated, oral spray, novel sublingual mucosal-based bacterial vaccine that reduces recurrent Urinary Tract Infections (rUTI).In clinical research, MV140 has been found to induce immune responses both systemically and in the genitourinary ...
CoviShield COVID-19 Vaccine - Precision Vaccinations News
WEBMay 6, 2024 · CoviShield™ COVID-19 Vaccine Clinical Trials, Dosage, Indication, Side Effects. AstraZeneca CoviShield™ COVID-19 (C19VAZ) vaccine is made from the ChAdOx1 virus, a weakened version of a common cold virus ().In addition, genetic material has been added to the ChAdOx1 construct, which is used to make proteins from the SARS-CoV-2 coronavirus called Spike glycoprotein (S).
Herpes Vaccine Candidate Advances in 2023 - Precision …
WEBJan 8, 2023 · When BioNTech SE announced that the first person was dosed in a first-in-human Phase 1 clinical trial with BNT163, a herpes simplex virus (HSV) vaccine candidate for the prevention of genital lesions caused by HSV-2 and potentially HSV-1, there was much enthusiasm generated by millions of people. BioNTech's placebo-controlled, observer-blinded, two-dose-escalation study was launched on ...
U.S. Government Takes Herpes Vaccine Development Lead
WEBApr 4, 2024 · To address this shortcoming, the U.S. government issued a Notice of Special Interest (NOSI) NOT-AI-24-028 on March 27, 2024, intending to stimulate additional focus on developing diagnostics, therapeutics, and vaccines targeting HSV. This NOSI, issued by the U.S. National Institute of Allergy and Infectious Diseases, focuses on furthering the ...
Multi-Country Herpes Immunotherapy Clinical Study Continues
WEBMar 5, 2024 · This multi-country research study is recruiting 332 healthy participants aged 18-40 years or those aged 18-60 years with recurrent genital herpes. Known as GSK3943104A, GSK Study #215336 is forecasted to conclude in May 2026. This HSVTI study will explore different formulations and be conducted in two parts:
Pritelivir (AIC316) Herpes Treatment 2023 - Precision Vaccinations …
WEBJun 24, 2023 · Pritelivir (AIC316) Herpes Treatment June 2023. AiCuris Anti-infective Cures AG Pritelivir is a highly potent inhibitor of Herpes Simplex Virus replication that belongs to a new chemical class and acts via a novel mechanism of action (inhibition of the viral helicase-primase enzyme complex), in contrast to currently used nucleoside analogues.The discovery of pritelivir resulted from systematic ...
Skip to content